Literature DB >> 389183

Plasma amino acids as predictors of the severity and outcome of sepsis.

H Freund, S Atamian, J Holroyde, J E Fischer.   

Abstract

Sepsis is a major catabolic insult resulting in a peripheral energy deficit which is made up in part by increased breakdown of lean body mass and oxidation of amino acids, principally the branched chain amino acids. The prognosis in any given case of sepsis is difficult to predict, but should theoretically be related to the degree of disturbance in peripheral energy deficit, which may in turn, be related to plasma amino acid pattern. In order to study whether this hypothesis was correct, plasma amino acids and some of their metabolic byproducts, the beta-hydroxyphenylethanolamines, were studied in 25 septic patients, and were used as discriminant variables in a series of computer performed discriminant analyses and multiple regressions. The two functions tested were the degree of metabolic septic encephalopathy as a determinant of the severity of sepsis and the final outcome in the septic patient. Plasma amino acid patterns exhibited elevated levels of the aromatic and sulfur containing amino acids, phenylalanine, tryosine, tryptophan, methionine, cysteine, and taurine, normal concentrations of alanine, and low normal concentrations of the branched chain amino acids, valine, leucine and isoleucine. Arginine levels, as previously noted, were very low. Patients not surviving the septic episode exhibited higher concentrations of aromatic and sulfur containing amino acids, while patients surviving sepsis had higher concentrations of the branched chain amino acids and arginine. When the degree of encephalopathy as a determinant of the severity of sepsis and step wise discriminant analysis with multiple crescent techniques were used, the best discriminant function between patients with and without encephalopathy was found to result from the interaction of cysteine, methionine, phenylalanine, isoleucine, leucine, and valine. These amino acids gave a correct classification in 82% of patients with no encephalopathy, and 80% of patients with septic encephalopathy. When the same amino acids were used for the discriminant analysis for patients dying of sepsis and patients surviving, the best discriminant function was achieved by using plasma concentrations of alanine, cysteine, methionine, isoleucine, arginine, tyrosine and phenylalanine resulting in 91% of the nonsurvivors, and 79% of the survivors correctly classified. The results suggest a close and significant relationship between the deranged energy metabolism and muscle protein breakdown in sepsis, and the outcome. This further suggests a central role for certain amino acids in perhaps predicting the severity of sepsis and its outcome.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389183      PMCID: PMC1344534          DOI: 10.1097/00000658-197911000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

Review 1.  Pathogenesis and therapy of hepatic coma.

Authors:  J E Fischer; R J Baldessarini
Journal:  Prog Liver Dis       Date:  1976

2.  Sulfur-containing amino acids in experimental hepatic coma in the dog and the monkey.

Authors:  A R Smith; F Rossi-Fanelli; H Freund; J E Fischer
Journal:  Surgery       Date:  1979-06       Impact factor: 3.982

3.  PROTEIN METABOLISM AFTER INJURY.

Authors:  A FLECK; H N MUNRO
Journal:  Metabolism       Date:  1963-09       Impact factor: 8.694

4.  Studies of the absorption and metabolism of glucose following injury; the systemic response to injury.

Authors:  J M HOWARD
Journal:  Ann Surg       Date:  1955-03       Impact factor: 12.969

5.  The neurological disorder associated with liver disease.

Authors:  R D ADAMS; J M FOLEY
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1953

6.  Post-traumatic metabolism: a multidisciplinary challenge.

Authors:  D P Cuthbertson
Journal:  Surg Clin North Am       Date:  1978-10       Impact factor: 2.741

7.  An enzymatic assay for octopamine and other beta-hydroxylated phenylethylamines.

Authors:  P B Molinoff; L Landsberg; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1969-12       Impact factor: 4.030

8.  Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis.

Authors:  J H James; J Escourrou; J E Fischer
Journal:  Science       Date:  1978-06-23       Impact factor: 47.728

9.  Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions.

Authors:  H R Freund; J A Ryan; J E Fischer
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

10.  Contribution of protein to caloric expenditure following injury.

Authors:  J H Duke; S B Jørgensen; J R Broell; C L Long; J M Kinney
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

View more
  47 in total

1.  In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxaemia.

Authors:  Maaike J Bruins; Wouter H Lamers; Alfred J Meijer; Peter B Soeters; Nicolaas E P Deutz
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  [Plasma amino acid concentrations and isoleucine-phenylalanine quotient in patients with acute myocardial infarct during amino acid infusion].

Authors:  K F Bodmann; P Jürgens
Journal:  Med Klin (Munich)       Date:  1997-07-15

3.  Augmented sensitivity to benzodiazepine in septic shock rats.

Authors:  T Komatsubara; Y Kadoi; S Saito
Journal:  Can J Anaesth       Date:  1995-10       Impact factor: 5.063

4.  Nitric oxide and L-arginine metabolism in a devascularized porcine model of acute liver failure.

Authors:  Vikram Sharma; Gabriella A M Ten Have; Lars Ytrebo; Sambit Sen; Christopher F Rose; R Neil Dalton; Charles Turner; Arthur Revhaug; Hans M H van-Eijk; Nicolaas E P Deutz; Rajiv Jalan; Rajeshwar P Mookerjee; Nathan A Davies
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

5.  Branched chain amino acid-enriched solutions in the septic patient. A randomized, prospective trial.

Authors:  R H Bower; M Muggia-Sullam; S Vallgren; J M Hurst; K A Kern; R LaFrance; J E Fischer
Journal:  Ann Surg       Date:  1986-01       Impact factor: 12.969

6.  Plasma-amino acid profiles in sepsis and stress.

Authors:  J P Vente; M F von Meyenfeldt; H M van Eijk; C L van Berlo; D J Gouma; C J van der Linden; P B Soeters
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

7.  The Metabolopathy of Tissue Injury, Hemorrhagic Shock, and Resuscitation in a Rat Model.

Authors:  Anne L Slaughter; Geoffrey R Nunns; Angelo D'Alessandro; Anirban Banerjee; Kirk C Hansen; Ernest E Moore; Christopher C Silliman; Travis Nemkov; Hunter B Moore; Miguel Fragoso; Kiara Leasia; Erik D Peltz
Journal:  Shock       Date:  2018-05       Impact factor: 3.454

8.  Plasma citrulline kinetics and prognostic value in critically ill patients.

Authors:  Gaël Piton; Cyril Manzon; Elisabeth Monnet; Benoit Cypriani; Olivier Barbot; Jean-Christophe Navellou; Franck Carbonnel; Gilles Capellier
Journal:  Intensive Care Med       Date:  2010-04       Impact factor: 17.440

9.  Cerebral net exchange of large neutral amino acids after lipopolysaccharide infusion in healthy humans.

Authors:  Ronan Mg Berg; Sarah Taudorf; Damian M Bailey; Carsten Lundby; Fin Stolze Larsen; Bente Klarlund Pedersen; Kirsten Møller
Journal:  Crit Care       Date:  2010-02-11       Impact factor: 9.097

10.  Significance of the changes in plasma amino-acid levels in meningococcal infection.

Authors:  R Conejero; A Lorenzo; F Arnal; J Garcia
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.